In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes

Journal of Immunology

Volumn 163, Issue 9, 1999, Pages 4909-4916

  Woo, Minna ^a   Hakem, Anne ^a   Elia, Andrew J ^a   Hakem, Razqallah ^a   Duncan, Gordon S ^a   Patterson, Bruce J ^b   Mak, Tak W ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c AMGEN INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOCHROME C; FAS ANTIGEN; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ANALYSIS; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASES; CYTOCHROME C GROUP; IN SITU NICK-END LABELING; INJECTIONS, INTRAPERITONEAL; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; STAINING AND LABELING; SURVIVAL ANALYSIS;

EID: 0032736175     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
2. Hengartner, M. O., and H. R. Horvitz. 1994. Programmed cell death in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 4:581.
3. Zou, H., W. J. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405.
4. Nicholson, D. W., and N. A. Thornberry. 1997. Caspases: killer proteases. Trends Biochem. Sci. 22:299.
5. Thornberry, N, A., and Y. Lazebnik. 1998. Caspases: enemies within. Science 281:1312.
6. Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3:409.
7. Galle, P. R., W. J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P. H. Krammer, and L. Runkel. 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223.
8. Ogasawara, J., F. R. Watanabe, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1995. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
9. Gamen, S., A. Anel, Pineiro A, and J. Naval. 1998. Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramide signalling pathway. Cell Death Differ. 5:241.
10. Woo, M., R. Hakem, M. S. Soengas, G. S. Duncan, A. Shahinian, D. Kagi, A. Hakem, M. McCurrach, W. Khoo, S. A. Kaufman, et al. 1998. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:806.
11. Yamada, K., F. Ichikawa, S. S. Ishiyama, X. Yuan, and K. Nonaka. 1999. Essential role of caspase-3 in apoptosis of mouse β-cells transfected with human Fas. Diabetes 48:478.
12. Rouquet, N., J. C. Pages, T. Molina, P. Briand, and V. Joulin. 1996. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr. biol. 6:1192.
13. Longthorne, V. I., and G. T. Williams. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J. 16:3805.
14. Rodriguez, I., K. Matsuura, K. Khatib, J. C. Reed, S. Nagata, and P. Vassalli. 1997. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 183:1031.
15. Jones, R.A., V. I. Johnson, N. R. Buck, M. Dobrota, R. H. Hinton, S. C. Chow, and G. E. Kass. 1998. Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases. Hepatology 27:1632.
16. Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85:803.
17. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLlCE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 85:817.
18. Srinivasula, S. M., M. Ahmad, T. Fernandes-Alnemri, G. Litwack, and E. S. Alnemri. 1996. Molecular ordering of the Fas-apoptotic pathway: the Fas/ APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA 93:14486.
19. Li P, D. Nijhawa, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479.
20. Luo, X., I. Budihardjo, H. Zou, C. Slaughter, and X. Wang. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481.
21. Li, H., H. Zhu, C. J. Xu, and J. Yuan. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491.
22. Slee, E. A., M. T. Harte, R. M. Kluck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, et al. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144:281.
23. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675.
24. Lacronique, V., A. Mignon, M. Fabre, B. Viollet, N. Rouquet, T. Molina, A. Porteu, A. Henrion, D. Bouscary, P. Varlet, et al. 1996. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2:80.
25. Kluck, R. M., W. E. Bossy, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132.
26. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129.
27. L through caspase interaction. Proc. Natl. Acad. Sci. USA 95:554.
28. Cheng, E. H., D. G. Kirsch, R. J. Clem, R. Ravi, M. B. Kastan, A. Bedi, K. Ueno, and J. M. Hardwick. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278:1966.
29. Pensati, L., A. Costanzo, A. Ianni, D. Accapezzato, R. Iorio, G. Natoli, R. Nisini, C. Almerighi, C. Balsano, P. Vajro, et al. 1997. Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology 113:1384.
30. Hayashi, N., and E. Mita. 1997. Fas system and apoptosis in viral hepatitis. J. Gastroenterol. Hepatol. 12:S223.
31. Strand, S., W. J. Hofmann, A. Grambihler, H. Hug, M. Volkmann, G. Otto, H. Wesch, S. M. Mariani, V. Hack, W. Stremmel, et al. 1998. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat. Med. 4:588.
32. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43.
33. L regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627.
34. Reed, J. C. 1997. Double identity for proteins of the Bcl-2 family. Nature 387: 773.
35. Kawahara, A., T. Kobayashi, and S. Nagata. 1998. Inhibition of Fas-induced apoptosis by Bcl-2. Oncogene 17:2549.
36. Chiu, V. K., C. M. Walsh, C. C. Liu, J. C. Reed, and W. R. Clark. 1995. Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. J. Immunol. 154:2023.
37. Memon, S. A., M. B. Moreno, D. Petrak, and C. M. Zacharchuk. 1995. Bcl-2 blocks glucocorticoid-but not Fas-or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:4644.
38. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621.
39. L can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA 94: 3759.
40. Rodriguez, I., K. Matsuura, C. Ody, S. Nagata, and P. Vassalli. 1996. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med 184:2067.
41. Zheng, T. S., S. F. Schlosser, T. Dao, R. Hingorani, I. N. Crispe, J. I. Boyer, and R. A. Flavell. 1998. Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. Proc. Natl. Acad. Sci. USA 95:13618.